QuidelOrtho Corp
QDELCIK 0001906324 · In Vitro & In Vivo Diagnostic Substances · Nasdaq
- Coronado Topco, Inc. (until 2022-04-11)
Revenue (TTM)
$2.63B
−1.9% YoY
Q1 Apr 2026
Net Income (TTM)
−$1.09B
+44.8% YoY
Q1 Apr 2026
EPS Diluted (TTM)
−$16.09
+45.4% YoY
Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-33.7%
Q1 Apr 2026
Net Margin
-41.6%
Q1 Apr 2026
Free Cash Flow (TTM)
−$1.5M
Q1 Apr 2026
Cash
$140.4M
Q1 Apr 2026
Total Debt
$2.93B
Q1 Apr 2026
Shares Outstanding
68.19M sh
Q1 Apr 2026